This is the comprehensive opioid use disorder legislation passed by the 115th Congress and signed into law by the president in 2018. The bill is known as the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, or the SUPPORT for Patients and Communities Act.
This 2018 report from the National Academy for State Health Policy describes strategies state and local leaders can adopt to promote recovery among pregnant and parenting women with opioid use disorder. It also features descriptions of programs in place in Colorado, Pennsylvania, and Texas.
This one page document summarizes the strategies health plans can use to reduce opioid overuse and misuse among their patient populations as described in the 2 California Health Care Foundation Reports. Funding Source: California Health Care Foundation
A 2016 report from the California Health Care Foundation on strategies health plans can adopt to address opioid overuse and misuse among their insured populations. The report provides examples of strategies in 4 areas: engaging providers, working with high-risk members, addressing misuse, and supporting healthy
This 2016 report profiles 3 California health plans that took aggressive actions to reduce opioid overuse and misuse among their patient populations and presents the results from their efforts. The report profiles the efforts of Partnership Health Plan of California, Blue Shield of California, and Kaiser Permanente Southern California. Prepared by the California Health Care Foundation. Funding Source: California Health Care Foundation
A 2017 white paper from the Academic Consortium for Integrative Medicine and Health, section one of this report reviews the current status of medical pain management and the nature of the pain crisis in America.
This 2017 publication from Smart Care California includes a checklist on specific steps health plans and purchasers can take to address 4 policy areas related to the opioid crisis: decreasing the number of patients starting on opioid therapy, improving pain management options, increasing access to addiction treatment
This 2017 publication from the California Health Care Foundation makes the case that commercial and public health plans should make access to medication assisted treatment (MAT) a priority for patients with opioid use disorder. The report explains why MAT is so important, defines the access barriers to MAT, and provides strategies for health plans to implement in making MAT available for their patients. Funding Source: California Health Care Foundation
Website for the California Health Care Foundation’s Opioid Safety Toolkit for Health Plans. The toolkit is designed to assist health plans in implementing opioid safety initiatives across their operations including their leadership structure, provider network, medical management policies, pharmacy benefits, and member